Our Investors

Transine has ambitious plans for developing and exploiting the SINEUP® technology across its broad applicability which are supported by expert investors, Takeda Ventures, Inc. and the Dementia Discovery Fund.

The Dementia Discovery Fund

The Dementia Discovery Fund (DDF) is a £250m specialist venture capital fund that invests in, and creates, new biotech companies to deliver high impact therapeutics for age-related dementias.

Takeda Ventures

Takeda Ventures, Inc. focuses on high-calibre therapeutic and platform based, early-stage opportunities around the world. It concentrates on areas aligned with Takeda’s R&D focus including oncology, gastroenterology, neuroscience, and rare disease.

Get in Touch

For more information about Transine, please email our team via info@transinetx.com or contact us below.

Contact us